Top Story

Dapagliflozin combination improved glycemic control, reduced body weight in type 2 diabetes

January 29, 2015

Dapagliflozin as an add-on to metformin plus sulfonylurea improved glycemic control and reduced body weight in patients with type 2 diabetes, according to recent study findings published in Diabetes Care.

Stephan Matthaei, MD, of the Diabetes-Zentrum Quakenbrück in Germany, and colleagues evaluated participants (mean age, 61 years) with an HbA1c of 7% to 10.5% receiving sulfonylurea and metformin who were assigned to receive dapagliflozin (Farxiga, Bristol-Myers Squibb and AstraZeneca) 10 mg/day (n=109) or placebo (n=109) to determine the effect on inadequate glycemic control.

James DiNicolantonio In the Journals

Type 2 diabetes fueled by added fructose

January 29, 2015
Current dietary guidelines allowing 25% of total daily calories as added sugars are being challenged by researchers who are proposing reductions in the amount of added…
Marjolein Zanders In the Journals

Diabetes drug adherence drops with cancer diagnoses

January 29, 2015
Adherence to glucose-lowering medications among patients with diabetes appears to diminish after they are diagnosed with cancer, according to research published in…
In the Journals

Patients with OA more likely to self-report lower weight, BMI

January 29, 2015
In Norway, patients with osteoarthritis were more likely to underreport their weight and BMI, according to recently published findings.A group of 600 patients, 449 of…
In the Journals

Insulin resistance-related lipoproteins linked to diabetes risk

January 28, 2015
Lipoprotein-based insulin resistance, very low density lipoprotein concentration and size, triglycerides and their ratio with HDL cholesterol were associated with…
More News Headlines »
Experts Take: Dialogue on HTG

Experts’ Take: Dialogue on Hypertriglyceridemia

This activity is supported by an independent educational grant from Amarin Pharma Inc.

Lead by genetic studies, recent data describe a causal role of triglycerides (TG) in the formation of atherosclerosis…
More »
Meeting News Coverage Video
Hatipoglu th

Autologous islet cell transplantation effective for chronic pancreatitis

December 3, 2014
In this video exclusive, Betul Hatipoglu, MD, clinical associate professor of medicine of the Endocrinology &…
More »
Acromegaly Cases

Acromegaly Cases: Expert Insights into Diagnosis and Emerging Treatment Options – Part 5 of 5

This activity is supported by an educational grant from Genentech.

Acromegaly is a rare chronic disorder that is typically caused by excessive growth hormone secretion, and is…
More »
Current Issues
View the Current Issues